Response of capillary cell death to aminoguanidine predicts the development of retinopathy: Comparison of diabetes and galactosemia

Investigative Ophthalmology and Visual Science

Volumn 41, Issue 12, 2000, Pages 3972-3978

  Kern, T S ^a   Tang, J ^a   Mizutani, M ^a   Kowluru, R A ^a   Nagaraj, R H ^a   Romeo, G ^a   Podesta, F ^a   Lorenzi, M ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AMINOGUANIDINE; GALACTOSE;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; DIABETIC RETINOPATHY; GALACTOSEMIA; GLYCATION; HISTOPATHOLOGY; NICK END LABELING; NONHUMAN; PERICYTE; PRIORITY JOURNAL; RAT; RETINA CAPILLARY;

ANIMALS; APOPTOSIS; CAPILLARIES; CELL SURVIVAL; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; ENDOTHELIUM, VASCULAR; GALACTOSE; GALACTOSEMIAS; GLYCOSYLATION END PRODUCTS, ADVANCED; GUANIDINES; IN SITU NICK-END LABELING; MALE; PERICYTES; RATS; RATS, SPRAGUE-DAWLEY; RETINAL VESSELS;

EID: 0033753702     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Patterns of ischemia in diabetic retinopathy
2. Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy
3. Comparison of retinal lesions in alloxandiabetic rats and galactose-fed rats
4. Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy
5. Aminoguanidine inhibits the development of accelerated diabetic retinopathy in the spontaneous hypertensive rat
6. Aminoguanidine does not inhibit the initial phase of experimental diabetic retinopathy in rats
7. Formation of pentosidine during nonenzymatic browning of proteins by glucose: Identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo
8. An aldose reductase inhibitor and aminoguanidine prevent vascular endothelial growth factor expression in rats with long-term galactosemia
9. Hemoglogin-AGE: A circulating marker of advanced glycosylation
10. Evidence of a glycemic threshold for the formation of pentosidine in diabetic dog lens but not in collagen
11. Protein crosslinking by the Maillard reaction: Dicarbonyl-derived imidazolium crosslinks in aging and diabetes
12. High correlation between pentosidine protein crosslinks and pigmentation implicates ascorbate oxidation in human lens senescence and cataractogenesis
13. Collagen browning and cross-linking are increased in chronic experimental hyperglycemia: Relevance to diabetes and aging
14. Immunological evidence for methylglyoxal-derived modifications in vivo: Determination of antigenic epitopes
15. Pharmacologic inhibition of diabetic retinopathy: Comparison of aminoguanidine and aspirin
16. Altered mRNA levels of antioxidant enzymes in pre-apoptotic pericytes from human diabetic retinas
17. Bax is increased in the retina of diabetic subjects and is associated with pericyte apoptosis in vivo and in vitro
18. Cell turnover of capillaries
19. Apoptosis of endothelial cells is associated with paracrine induction of adhesion molecules: Evidence for an interleukinbeta-dependent paracrine loop
20. Apoptotic vascular endothelial cells become procoagulant
21. Discordant effects of guanidines on renal structure and function and on regional vascular dysfunction and collagen changes in diabetic rats
22. Chronic dosing with aminoguanidine and novel advanced glycosylation end product-formation inhibitors ameliorates cross-linking of tail tendon collagen in STZ-induced diabetic rats
23. Prevention of diabetes-increased aging effect on rat collagen-linked fluorescence by aminoguanidine and rutin
24. Secondary intervention with aminoguanidine retards the progression of diabetic retinopathy in rat model
25. Thiamine pyrophosphate and pyridoxamine inhibit the formation of antigenic advanced glycation end-products: Comparison with aminoguanidine
26. Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozocin-induced diabetic rat
27. Relative contributions of advanced glycation and nitric oxide synthase inhibition to aminoguanidine-mediated renoprotection in diabetic rats
28. Prevention of diabetic vascular dysfunction by guanidines: Inhibition of nitric oxide synthase versus advanced glycation end-product formation
29. Aminoguanidine inhibits albuminuria, but not the formation of advanced glycation end-products in skin collagen of diabetic rats
30. Aminoguanidine effects on nerve blood flow, vascular permeability, electrophysiology, and oxygen free radicals
31. Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction
32. The relative roles of advanced glycation, oxidation and aldose reductase inhibiton in the development of experenmental diabetic nephropathy in the Sprague-Dawley rat
33. Aminoguanidine inhibits semicarbazide-sensitive amine oxidase activity: Implications for advanced glycation and diabetic complications
34. Efficient scavenging of fatty acid oxidation products by aminoguanidine
35. Nitric oxide synthase activity and L-arginine metabolism in the retinas from streptozotocin-induced diabetic rats
36. Aminoguanidine inhibits reactive oxygen species formation, lipid peroxidation, and oxidant-induced apoptosis
37. Effects of aminoguanidine on hyperglycemia-induced retinal metabolic abnormalities